SFX by Ex Libris Inc.

Title:	Chemistry: Chemical con artists foil drug discovery
Source:	Nature [0028-0836] Baell, J yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chou Tsui-Fen, Raymond u. "Specific Inhibition of p97/VCP ATPase and Kinetic Analysis Demonstrate Interaction between D1 and D2 ATPase domains." Journal of Molecular Biology 426.15 (2014): 2886-99.
description	2.	Baell, Jonathan B. "Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds." Journal of chemical information and modeling 53.1 (2012): 39-55.
description	3.	Baell, Jonathan B. "New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays." Journal of medicinal chemistry 53.7 (2010): 2719-2740.
description	4.	Lepre, CA. "Library design for NMR-based screening." Drug discovery today 6.3: 133-140.
description	5.	Verdine, Gregory L. "The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members." Clinical cancer research 13.24 (2007): 7264-7270.
description	6.	Walensky, Loren D D. "Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix." Science 305.5689 (2004): 1466-1470.
description	7.	Walters, Mark P. "Prediction of ‘drug-likeness’." Advanced drug delivery reviews 54.3 (2002): 255-271.
description	8.	Mendgen, T. "Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry." Journal of medicinal chemistry 55.2 (2012): 743-753.
description	9.	Walensky, Loren D. "A stapled BID BH3 helix directly binds and activates BAX." Molecular cell 24.2 (2006): 199-210.
description	10.	Yamada Okabe, H. "Use of genomics in drug discovery: Application to target identification, high-throughput screening and diagnosis." 日本農薬学会誌 26.3 (2001): 305-308.
description	11.	Baell, J. "Chemical con artists foil drug discovery." Nature 513.7519 (2014): 481-483.
description	12.	Dahlin Jayme L, Jayme n. "Pneumocystis jirovecii PjRtt109: A Novel Drug Target for Pneumocystis Pneumonia in Immunosuppressed Humans." Antimicrobial agents and chemotherapy 58.7 (2014): 3650-9.
description	13.	Johnson, Steven M. "A biochemical screen for GroEL/GroES inhibitors." Bioorganic and medicinal chemistry letters 24.3 (2014): 786-789.
description	14.	Dahlin Jayme L, Jayme n. "A cell-free fluorometric high-throughput screen for inhibitors of rtt109-catalyzed histone acetylation." PLoS ONE 8.11 (2013).
description	15.	Zhu, Y. "Target-oriented synthesis: miscellaneous synthetic routes to access 1,4-enediones through the coupling of 1,3-dicarbonyl compounds with multiform substrates." Tetrahedron 69.31 (2013): 6392-6398.
description	16.	Chou, T. "Structure-Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase." ChemMedChem 8.2 (2013): 297-312.
description	17.	Saubern, S. "KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries." Molecular informatics 30.10 (2011): 847-850.
description	18.	Bobzin, S. "Application of liquid chromatography-nuclear magnetic resonance spectroscopy to the identification of natural products." Journal of chromatography. Biomedical applications 748.1 (2000): 259-267.
description	19.	Hajduk, Philip J. "Privileged molecules for protein binding identified from NMR-based screening." Journal of medicinal chemistry 43.18 (2000): 3443-3447.
description	20.	Coles, M. "NMR-based screening technologies." Drug discovery today 8.17 (2003): 803-810.